NRI from all over the world (including U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹427.18
1.08%
NAV as on 25 Apr 24, 12:00 AM
very high risk
sector healthcare
equity
NAV as on 25 Apr 24, 12:00 AM
very high risk
sector healthcare
equity
52.35%p.a.
Last 1Y
16.08%p.a.
Last 3Y
22.69%p.a.
Last 5Y
20.88%p.a.
Since Inception
About Nippon India Pharma Fund - Growth for NRIs
NRIs can achieve long-term capital appreciation by investing in the Nippon India Pharma Fund - Growth scheme from Nippon Life India Asset Management Ltd. It is a Sector - Healthcare mutual fund scheme that predominantly invests in Sector - Healthcare stocks of companies. Launched on Jun 2004, Nippon India Pharma Fund - Growth is Sector - Healthcare fund of its category with 7,125.28 Cr fund under management as on Apr 2024. The expense ratio of this fund is less than that of most other Fund category Sector - Healthcare funds.
- Nippon India Pharma Fund - Growth delivered 52.4% annual returns during the last year. It has delivered 20.9% average annual returns since the fund was launched.
- Nippon India Pharma Fund - Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
- The scheme has predominantly invested in equity
Fund Objective
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd
14.91%
Lupin Ltd
8.40%
Cipla Ltd
6.51%
Apollo Hospitals Enterprise Ltd
5.79%
Dr Reddy's Laboratories Ltd
4.75%
Gland Pharma Ltd
4.40%
Divi's Laboratories Ltd
4.36%
Zydus Lifesciences Ltd
4.18%
J.B. Chemicals & Pharmaceuticals Ltd
3.44%
Abbott India Ltd
3.29%
Fund Managers
- Sailesh Raj Bhan (Apr 2005 - Present)
- Kinjal Desai (May 2018 - Present)
Key Information
View Scheme Document
Nippon India Pharma Fund - Growth SIP Calculator
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
NRI Mutual Fund Tax on Nippon India Pharma Fund - Growth
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
How can NRIs invest in Nippon India Pharma Fund - Growth?
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
- Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
- PAN Number
- Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
- Passport – front and back
- Passport size photograph
- signature
If all details are correct, your KYC will be approved within 7 to 8 business days.
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in Nippon India Pharma Fund - Growth
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
- City and country of birth
- NRE/NRO bank account statement/ canceled cheque for the latest 3 months
- Nominee details
Similar Funds
Funds
3Y Return
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
very high risk | equity
18.3%
SBI Healthcare Opportunities Fund Growth
very high risk | equity
17.9%
DSP Healthcare Fund Growth
very high risk | equity
16.5%
Frequently Asked Questions
Copyright | 2021 @ SBNRI | All Rights Reserved